Skip to content

Lethal Congenital Malformations: Palliative Therapy From An Islamic Point of View

Palliative Therapy For Lethal Congenital Malformations: An Islamic Perspective

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02985385
Acronym
LCM
Enrollment
25958
Registered
2016-12-07
Start date
2001-06-30
Completion date
2005-12-31
Last updated
2016-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Malformations

Keywords

Congenital Lethal Malformations

Brief summary

To prove that palliative therapy can be practised for congenital lethal malformations within the Islamic Code of Ethics. After defining lethal malformation no respiratory support is offered and newborns are provided with compassionate care.

Detailed description

This is a prospective observational study where all abnormal antenatal ultrasounds are discussed in a weekly prenatal meeting and plans are drawn for management of these abnormal fetal findings. Lethal malformations are defined as conditions which will end in death regardless of supportive care. Cases are discussed extensively and parents are involved in management decisions. When a decision of non- intervention is reached for a lethal malformation consent of the family is obtained and a plan of non monitoring for the mother is documented together with no resuscitation for the newborn. Families who do not consent to such plan are offered full support for the pregnant mother and her newborn. A record of all cases is kept available together with the management plan so that the appropriate action is taken when the the pregnant lady presents for admission. All babies with lethal malformations are recorded whether stillborn or live born and their diagnosis is confirmed. Survival time is recorded for each case.

Interventions

OTHERPalliative management

Diagnostic studies for abnormal fetal ultrasounds

Sponsors

Security Forces Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Hours to 1 Hours
Healthy volunteers
No

Inclusion criteria

All babies with abnormal fetal ultrasounds -

Exclusion criteria

Normal babies who die in the neonatal period because of other causes not associated with lethal malformations \-

Design outcomes

Primary

MeasureTime frameDescription
Effective Palliative therapy in lethal malformationsTime of death in days for a baby with lethal malformationProvide palliative care only to those babies born with lethal congenital malformations in the form of oxygen and feeding

Secondary

MeasureTime frameDescription
Survival of babies with lethal malformationsTime of survival in hours or daysRecord of the time of survival for each group of lethal malformations

Countries

Saudi Arabia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026